ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

STX Shield Therapeutics Plc

1.525
0.05 (3.39%)
May 10 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2022 20152016201720182019202020212022
GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)GBP (£)
Total Revenue 0304k637k11.88M719k10.39M1.52M4.47M
Operating Income -6.43M-12.46M-20.95M-5.16M-9.04M-2.15M-20.29M-40.41M
Pre Tax Income -24.49M-15.6M-20.99M-5.15M-9.07M-1.89M-19.91M-40.08M
Net Income -23.63M-15.02M-19.59M-1.79M-8.8M-2.63M-19.68M-40.44M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -34.2-21.8-16.8-1.5-7.5-2.2-9.1-15.6
EBIT -6.43M-12.46M-20.95M-5.16M-9.04M-2.15M-20.29M-40.41M
EBITDA -6.38M-10.52M-18.51M-2.47M-6.41M551k-18.09M-23.34M